Correlation of glutathione S-transferases with overall survival in patients with gastric carcinoma

International Journal of Oncology

Volumn 9, Issue 2, 1996, Pages 357-363

  Schipper, D Lucette ^a   Verspaget, Hein W ^b   Mulder, Theo P J ^a   Sier, Cornelis F M ^b   Ganesh, Sjam ^b   Roelofs, Hennie M J ^a   Peters, Wilbert H M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Gastric cancer; Glutathione S transferase; Survival analysis

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA;

EID: 0030056480     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.2.357     Document Type: Article

References (47)

1. Boyer TD and Kenney WC: Preparation, characterization and properties of glutathione S-transferases. Biochem Pharmacol Toxicol 1: 297-363, 1985.
2. Mannervik B: The isoenzymes of glutathione S-transferase. Adv Enzymol 57: 357-417, 1985.
3. Tew KD: Glutathione-associated enzymes in anti-cancer drug resistance. Cancer Res 54: 4313-4320, 1994.
4. Tsuchida S and Sato K: Glutathione transferases and cancer. Crit Rev Biochem Mol Biol 27: 337-384, 1992.
5. Meyer JD, Coles B, Pemble SE, Gilmore KS, Fraser GM and Ketterer B: Theta, a new class of glutathione transferases purified from rat and man. Biochem J 274: 409-414, 1991.
6. Peters WHM, Roelofs HMJ, Hectors MPC, Nagengast FM and Jansen JBMJ: Glutathione and glutathione S-transferases in Barrett's epithelium. Br J Cancer 67: 1413-1417, 1993.
7. Peters WHM, Wormskamp NGM and Thies E: Expression of glutathione S-transferases in normal gastric mucosa and in gastric tumors. Carcinogenesis 11: 1593-1596, 1990.
8. Howie AF, Forrester LM, Glancey MJ, Schlager JJ, Powis G, Beckett GJ, Hayes JD and Wolf CR: Glutathione S-transferase and glutathione peroxidase expression in normal and tumour human tissues. Carcinogenesis 11: 451-458, 1990.
9. Gilbert L, Elwood LJ, Merino M, Masood S, Barnes R, Steinberg SM, Lazarous DF, Pierce L, d'Angelo T, Moscow JA, Townsend AJ and Cowan KH: A pilot study of Pi-class glutathione S-transferase expression in breast cancer: Correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J Clin Oncol 11: 49-58, 1993.
10. Mulder TPJ, Verspaget HW, Sier CFM, Roelofs HMJ, Ganesh S, Griffioen G and Peters WHM: Glutathione S-transferase Pi in colorectal tumors is predictive for overall survival. Cancer Res 55: 2696-2702, 1995.
11. Hermanek P and Sobin LH: Digestive system tumours. In: TNM classification of malignant tumours (U.I.C.C.). Springer-Verlag, Berlin pp38-67, 1987.
12. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Path Microbiol Scand 64: 31-49, 1965.
13. Peters WHM, Boon CEW, Roelofs HMJ, Wobbes Th, Nagengast FM and Kremers PG: Expression of drug-metabolizing enzymes and P-170 glycoprotein in colorectal carcinoma and normal mucosa. Gastroenterology 103: 458-455, 1992.
14. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
15. Habig WH, Pabst MJ and Jakoby WB: Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139, 1974.
16. Peters WHM, Kock L, Nagengast FM and Roelofs HMJ: Immunodetection with a monoclonal antibody of glutathione S-transferase mu in patients with and without carcinomas. Biochem Pharmacol 39: 591-597, 1990.
17. Van Ommen B, Bogaards JJP, Peters WHM, Blauwboer B and van Bladeren PJ: Quantification of human hepatic glutathione S-transferases. Biochem J 269: 609-613, 1990.
18. Peters WHM, Nagengast FM and Wobbes Th: Glutathione S-transferases in normal and cancerous human colon tissue. Carcinogenesis 10: 2371-2374, 1989.
19. Cox DR: Regression models and life-tables. J R Stat Soc B 34: 187-220, 1972.
20. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
21. Boring CC, Squires TS, Tong T and Montgomery S: Cancer statistics. CA Cancer J Clin 44: 7-26, 1994.
22. Diehl JT, Hermann RE, Coopeerman, et al: Gastric carcinoma: a ten-year review. Ann Surg 198: 9-12, 1983.
23. Sue-Ling HM, Johnston D, Martin IG, Dixon MF, Lansdown MRJ, McMahon MJ and Axon ATR: Gastric cancer: a curable disease in Britain. Br Med J 307: 591-596, 1993.
24. Bizer LS: Adenocarcinoma of the stomach: current results of treatment. Cancer 51: 743-745, 1983.
25. Siewert JR, Boettcher K, Roder JD, Busch R, Hermanek P, Meyer HJ and the German Gastric Carcinoma Study Group: Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 80: 1015-1018, 1993.
26. Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, van Elk P, Obertop H, Gouma DJ, Taat CW, van Lanschot J, Meyer S, de Graaf PW, von Meyenfeldt MF, Tilanus H and van de Velde CJH: Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345: 742-743, 1995.
27. Ichikura T, Tomimatsu S, Okusa Y, Eefuji K and Tamakuma S: Comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage based on their location in patients with gastric cancer. J Clin Oncol 11: 1894-1900, 1993.
28. Rougier Ph, Lasser Ph, Ducreux M, Mahjoubi M, Bognel C and Elias D: Preoperative chemotherapy of locally advanced gastric cancer. Ann Oncol 5 (Suppl. 3): S59-S68, 1994.
29. Kelsen D: Neoadjuvant therapy for gastrointestinal cancers. Oncology 7: 25-41, 1993.
30. Iwasaki K, Torisu M and Fujimura T: Malignant tumor and eosinophils. I. Prognostic significance in gastric cancer. Cancer 58: 1321-1327, 1986.
31. Clapper ML, Hoffman SJ and Tew KD: Glutathione S-transferases in normal and malignant human colon tissue. Biochim Biophys Acta 1096: 209-216, 1991.
32. Moorghen M, Cairns J, Forrester LM, Hayes JD, Hall A, Cattan AR, Wolf CR and Harris AL: Enhanced expression of glutathione S-transferases in colorectal carcinoma compared to non-neoplastic mucosa. Carcinogenesis 12: 13-17, 1991.
33. Koberda J and Hellmann A: Glutathione S-transferase activity of leukemic cells as a prognostic factor for response to chemotherapy in acute leukemias. Med Oncol Tumor Pharmacather 8: 35-38, 1991.
34. Tidefeld U, Elmhorn-Rosenborg A, Paul C, Hoa X-Y, Mannervik B and Eriksson LC: Expression of glutathione transferase Pi as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia. Cancer Res 52: 3281-3285, 1992.
35. Hamada S-I, Kamada M, Furumoto H, Hirao T and Aono T: Expression of glutathione S-transferase-Pi in human ovarian cancer as an indicator of resistance to chemotherapy. Gynecol Oncol 52: 313-319, 1994.
36. Green JA, Robertson LJ and Clark AH: Glutathione S-transferase expression in benign and malignant ovarian tumours. Br J Cancer 68: 235-239, 1993.
37. Murphy D, McGown AT, Hall A, Cattan A, Crowther D and Fox BW: Glutathione S-transferase activity and isoenzyme distribution in ovarian tumour biopsies taken before and after cytotoxic chemotherapy. Br J Cancer 66: 937-942, 1992.
38. van der Zee AGJ, van Ommen B, Meijer C, Hollema H, van Bladeren PJ and de Vries EGE: Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy. Br J Cancer 66: 930-936, 1992.
39. 6-alkylguanine-DNA-alkyltransferase and P-glycoprotein in adult patients with leukaemia. Br J Haematol 85: 103-111, 1993.
40. Wright C, Cairns J, Cantwell BJ, Cattan AR, Hall AG, Harris AL and Home CHW: Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S-transferases. Br J Cancer 65: 271-274, 1992.
41. Peters WHM, Roelofs HMJ, van Putten WLJ, Jansen JBMJ, Klijn JGM and Foekens JA: Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases. Br J Cancer 68: 86-92, 1993.
42. Grignon DJ, Abdel-Malak M, Mertens WC, Sakr WA and Shepherd RR: Glutathione S-transferase expression in renal cell carcinoma: A new marker of differentiation. Mod Pathol 7: 186-189, 1994.
43. Toffoli G, Frustaci S, Tumiotto L, Talamini R, Gherlinzoni F, Picci P and Boiocchi F: Expression of MDR1 and GST Pi in human soft tissue sarcomas: relation to drug resistance and biological aggressiveness. Ann Oncol 3: 63-69, 1992.
44. Okuyama K, Maehara Y, Endo K, Baba H, Adachi Y, Kuwano M and Sugimachi K: Expression of glutathione S-transferase-Pi and sensitivity of human gastric cancer cells to cisplatin. Cancer 74: 1230-1236, 1994.
45. Tsutsumi M, Sugisaki T, Makino T, Miyagi N, Nakatani K, Shiratori T, Takahashi S and Konishi Y: Oncofetal expression of glutathione S-transferase placental form in human stomach carcinomas. Jpn J Cancer Res 78: 631-633, 1987.
46. Strange RC, Matharoo B, Faulder GC, Jones P, Cotton W, Elder JB and Deakin M: The human glutathione S-transferases: a case-control study of the incidence of GST 1 0 phenotype in patients with adenocarcinoma. Carcinogenesis 12: 25-28, 1991.
47. Seidegard J, Pero RW, Markowitz MM, Roush G, Miller DG and Beattie EJ: Isoenzymes of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow-up study. Carcinogenesis 11: 33-36, 1990.